🔗 Share this article

An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users injecting products of uncertain source.

Several experts said the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Elimination

According to TikTok, the platform has removed violative material and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home.

Within moments of entering one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Costs

Within these groups, messages display dark colored parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious health risks”.